Details for 2021192867
Up to date per 02.04.2026
Actions
Details for 2021192867
Granted/Registered
European Patent
19.01.2022 A
29.11.2023 B1
21.09.2015
US
201562221191 P
30.01.2016
US
201662289221 P
A61K 31/454 20060101AFI20211126BHEP
Owner
Lumos Pharma, Inc.4200 Marathon Blvd. Suite 200 Austin, TX 78756US
Representative
Authorized Recipients
Paul CosmoviciGumpendorfer Straße 1421060 WienAT
Inventor
THORNER, Michael Charlottesville, 22903US
Information about Fees